AGENUS INC (AGEN) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001098972 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $34.5M | — | $-0.01 | Filing |
| Mar 31, 2026 | May 11, 2026 | $33.7M | — | $1.02 | Filing |
| Dec 31, 2025 | Mar 16, 2026 | $34.2M | — | $0.09 | Filing |
| Sep 30, 2025 | Nov 10, 2025 | $30.2M | — | $1.94 | Filing |
| Jun 30, 2025 | Aug 11, 2025 | $25.7M | — | $-1.00 | Filing |
| Mar 31, 2025 | May 12, 2025 | $24.1M | — | $-1.03 | Filing |
| Dec 31, 2024 | Mar 11, 2025 | $26.8M | — | $-1.95 | Filing |
| Sep 30, 2024 | Nov 12, 2024 | $25.1M | — | $-3.08 | Filing |
What would AGENUS INC have to report for its valuation to change?
At $6.04, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -29.9% a year, to $0.52. On that path the next quarter needs diluted EPS near $1.36, against $1.94 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -29.9% | -29.9% |
| EPS needed in final year | $0.52 | $0.52 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. AGEN goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.